These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 2022719)

  • 1. Human nonspecific suppressive lymphokines.
    Halpern MT
    J Clin Immunol; 1991 Jan; 11(1):1-12. PubMed ID: 2022719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of human natural and antibody-dependent cytotoxicity by soluble factors from unstimulated normal lymphocytes.
    Nair MP; Schwartz SA
    J Immunol; 1982 Dec; 129(6):2511-8. PubMed ID: 6183335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of a pokeweed mitogen-stimulated plaque-forming cell response by a human B lymphocyte-derived aggregated IgG-stimulated suppressor factor: suppressive B cell factor (SBF).
    Pisko EJ; Foster SL; White RE; Panetti M; Turner RA
    J Immunol; 1986 Mar; 136(6):2141-50. PubMed ID: 2419423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A human soluble suppressor factor affecting lymphocyte responses in vitro.
    Shou L; Schwartz SA; Good RA; Peng R; Chen CL
    Proc Natl Acad Sci U S A; 1980 Oct; 77(10):6096-100. PubMed ID: 6449702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble factors in tolerance and contact sensitivity to DNFB in mice. VI. Cellular and lymphokine requirements for stimulating suppressor factor production in vitro.
    Fairchild RL; Moorhead JW
    J Immunol; 1986 Oct; 137(7):2125-31. PubMed ID: 2944949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibodies to guinea pig lymphokines. II. Suppression of delayed hypersensitivity reactions by a "second generation" goat antibody against guinea pig lymphokines.
    Geczy CL; Geczy AF; De Weck AL
    J Immunol; 1976 Jul; 117(1):66-72. PubMed ID: 1084371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel lymphokine derived from human IgG Fc receptor-bearing B cells: its suppressive effect on activated T and B lymphocytes including tumour cells in vitro.
    Suzuki T; Park YH; Miyama-Inaba M; Masuda T; Saji H; Nagata I; Uchino H
    Immunology; 1985 Jul; 55(3):427-36. PubMed ID: 3160654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of a soluble suppressor of human B cell function produced by a continuous human suppressor T cell line. II. Evidence for suppression through a direct action of CTC-SISS-B on human B cells.
    Greene WC; Fleisher TA; Depper JM; Leonard WJ; Stanton GJ; Waldmann TA
    J Immunol; 1982 Sep; 129(3):1120-3. PubMed ID: 6213708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retrovirus-mediated immunosuppression. I. FeLV-UV and specific FeLV proteins alter T lymphocyte behavior by inducing hyporesponsiveness to lymphokines.
    Orosz CG; Zinn NE; Olsen RG; Mathes LE
    J Immunol; 1985 May; 134(5):3396-403. PubMed ID: 2984289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel mechanisms of specific suppression of anti-hapten antibody response mediated by monoclonal anti-carrier antibody.
    Sumida T; Taniguchi M
    J Immunol; 1985 Jun; 134(6):3675-81. PubMed ID: 3157746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of suppression in the transfer of contact sensitivity. Analysis of an I-J+ molecule required for Ly2 suppressor cell activity.
    Ptak W; Gershon RK; Flood PM
    J Exp Med; 1983 Dec; 158(6):1822-35. PubMed ID: 6196432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of in vitro CML generation by alloactivated lymphocytes: analysis of antigen-nonspecific suppressive mechanisms.
    Orosz CG; Ferguson RM
    J Immunol; 1985 Jan; 134(1):45-50. PubMed ID: 3155467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell mediated immunity and the inflammatory system.
    Cohen S
    Hum Pathol; 1976 May; 7(3):249-64. PubMed ID: 773808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of human cytotoxic lymphocyte responses. II. Suppression by a soluble factor produced by primed lymphocytes.
    Crosier PS; Broom BC
    Immunology; 1981 May; 43(1):19-24. PubMed ID: 6454647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Suppressor T- and B-lymphocytes].
    Khaitov RM
    Probl Gematol Pereliv Krovi; 1981 Oct; 26(10):48-54. PubMed ID: 6459576
    [No Abstract]   [Full Text] [Related]  

  • 16. Fc receptor-dependent immune-regulation: immunological roles of immune suppressive lymphokines (suppressive B cell factor), produced by Fc receptor-stimulated murine and human B cells.
    Masuda T; Miyama-Inaba M; Suzuki T; Park YH
    Nihon Ketsueki Gakkai Zasshi; 1984 Dec; 47(8):1623-31. PubMed ID: 6335810
    [No Abstract]   [Full Text] [Related]  

  • 17. Biological control of lymphokine function.
    Yoshida T; Cohen S
    Fed Proc; 1982 Jun; 41(8):2480-3. PubMed ID: 7044831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble factors in tolerance and contact sensitivity to 2,4-dinitrofluorobenzene in mice. I. Suppression of contact sensitivity by soluble suppressor factor released in vitro by lymph node cell populations containing specific suppressor cells.
    Moorhead JW
    J Immunol; 1977 Jul; 119(1):315-21. PubMed ID: 874323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role and function of antigen nonspecific suppressor factors.
    Aune TM
    Crit Rev Immunol; 1987; 7(2):93-130. PubMed ID: 2438085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macrophage activation to kill Leishmania tropica: characterization of a T cell-derived factor that suppresses lymphokine-induced intracellular destruction of amastigotes.
    Nacy CA
    J Immunol; 1984 Jul; 133(1):448-53. PubMed ID: 6202789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.